1858 — Beijing Chunlizhengda Medical Instruments Co Income Statement
0.000.00%
Last trade - 00:00- HK$5.04bn
- HK$2.51bn
- CNY1.05bn
Annual income statement for Beijing Chunlizhengda Medical Instruments Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,108 | 1,202 | 1,209 | 806 | 1,046 |
| Cost of Revenue | |||||
| Gross Profit | 844 | 900 | 855 | 516 | 653 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 741 | 873 | 903 | 675 | 744 |
| Operating Profit | 368 | 329 | 306 | 131 | 302 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 367 | 337 | 306 | 132 | 302 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 322 | 308 | 278 | 125 | 273 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 322 | 308 | 278 | 125 | 273 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 322 | 308 | 278 | 125 | 273 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.93 | 0.78 | 0.72 | 0.363 | 0.711 |
| Dividends per Share |